Učitavanje...

How we treat cytomegalovirus in hematopoietic cell transplant recipients

Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted preemptive antiviral treatment or prophylaxis strategies to prevent CMV disease. Both strategies are effective but also have shortcomings with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Boeckh, Michael, Ljungman, Per
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2700312/
https://ncbi.nlm.nih.gov/pubmed/19299333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-143560
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!